Articles by Zachary Bessette
Dr. Deek shares what research should be done to better personalize care for patients with oligometastatic prostate cancer.
Dr. Deek shares what “high-risk mutation” signified in his study and how patients with “high-risk mutation” should be ...
Dr. Deek shares how PSMA imaging used in both the STOMP and ORIOLE trials.
Dr. Deek shares how he evaluated long-term outcomes of MDT in om CSPC in both the ORIOLE and STOMP trials.
Joshua Meeks, MD, PhD, discusses ongoing research in NMIBC and the future of urothelial carcinoma care.
Intracorporeal DUBC may be a safe and effective alternative to RNU for UTUC, according to a new research.
Dr. Ulaner highlights the line(s) of therapy in which novel RLT-PSMA agents are being developed.
Dr. Ulaner explains the data that led to the FDA approval of 177Lu-PSMA-617 and the safety profile of this drug.
Dr. Ulaner details the current application and capabilities of molecular imaging in prostate cancer.
Moffitt Cancer Center developed the first PRO measure for patients receiving RNT to guide treatment and improve QoC.
670 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.